Investigators studied the effect of sequential valrubicin and docetaxel in patients with recurrent NMIBC following treatment with intravesical bacillus Calmette-Guérin and/or gemcitabine-docetaxel.
The risk of death from cardiovascular disease was elevated regardless of the duration of androgen deprivation therapy.
For patients treated with adequate BCG, risk for BCG unresponsiveness, progression similar for all high-grade Ta tumors.
A review of the critical role of oncology nurses in optimal palliative and supportive care for patients with advanced penile cancer.
Study explores the effect of a novel nursing model on quality of life measures in older patients with bladder cancer after ileal bladder replacement.
A propensity-score matched comparison revealed no significant difference in oncologic outcomes between radical cystectomy and trimodal therapy.
Five-year freedom from progression rate higher for those receiving short-term ADT and PLNRT in addition to salvage PBRT.
Short-term androgen deprivation therapy alone or in combination with pelvic lymph node radiotherapy can improve the efficacy of prostate bed radiotherapy.
Patients receiving nivolumab had an approximately 30 percent lower likelihood of developing cancer recurrence versus placebo.
The risk of dying from a subsequent primary cancer remained significantly elevated for 20 years or more for some patients.
